Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Donald E Mager

Showing results (1-10 of 163) with videos related to

Pageof 17
Sort By:
Advanced Drug Delivery Reviews|November 10, 2006
Quantitative structure-pharmacokinetic/pharmacodynamic relationshipsDonald E Mager
Biochemical Pharmacology|February 14, 2006
Target-mediated drug disposition and dynamicsDonald E Mager
Handbook of Experimental Pharmacology|May 5, 2025
Breadth of Pharmacology Modeling: Fundamentals of Pharmacokinetics, Pharmacodynamics, and Mechanistic ModelingDonald E Mager
British Journal of Pharmacology|March 31, 2022
Systems model identifies baseline cytokine concentrations as potential predictors of rheumatoid arthritis inflammatory response to biologicsTomohisa Nakada, Donald E Mager
Expert Opinion on Drug Metabolism & Toxicology|November 26, 2010
Quantitative structure-pharmacokinetic relationshipsChao Xu, Donald E Mager
Drug Metabolism and Disposition: the Biological Fate of Chemicals|November 7, 2012
Mechanisms of subcutaneous absorption of rituximab in ratsLeonid Kagan, Donald E Mager
Journal of Pharmacokinetics and Pharmacodynamics|January 16, 2020
Population-based meta-analysis of bortezomib exposure-response relationships in multiple myeloma patientsLi Zhang, Donald E Mager
Pharmaceutical Research|January 9, 2019
Machine Learning Models for the Prediction of Chemotherapy-Induced Peripheral NeuropathyPeter Bloomingdale, Donald E Mager
British Journal of Clinical Pharmacology|September 22, 2016
Population pharmacokinetics of exenatideBrenda Cirincione, Donald E Mager
CPT: Pharmacometrics & Systems Pharmacology|November 25, 2025
B Cell Differentiation Model for Identifying Predictors of Responses to Rituximab-Mediated B Cell Depletion in Rheumatic DiseasesTomohisa Nakada, Donald E Mager
Pageof 17

Showing results (1-10 of 163) with videos related to

Sort By:
Pageof 17
Advanced Drug Delivery Reviews|November 10, 2006
Quantitative structure-pharmacokinetic/pharmacodynamic relationshipsDonald E Mager
Biochemical Pharmacology|February 14, 2006
Target-mediated drug disposition and dynamicsDonald E Mager
Handbook of Experimental Pharmacology|May 5, 2025
Breadth of Pharmacology Modeling: Fundamentals of Pharmacokinetics, Pharmacodynamics, and Mechanistic ModelingDonald E Mager
British Journal of Pharmacology|March 31, 2022
Systems model identifies baseline cytokine concentrations as potential predictors of rheumatoid arthritis inflammatory response to biologicsTomohisa Nakada, Donald E Mager
Expert Opinion on Drug Metabolism & Toxicology|November 26, 2010
Quantitative structure-pharmacokinetic relationshipsChao Xu, Donald E Mager
Drug Metabolism and Disposition: the Biological Fate of Chemicals|November 7, 2012
Mechanisms of subcutaneous absorption of rituximab in ratsLeonid Kagan, Donald E Mager
Journal of Pharmacokinetics and Pharmacodynamics|January 16, 2020
Population-based meta-analysis of bortezomib exposure-response relationships in multiple myeloma patientsLi Zhang, Donald E Mager
Pharmaceutical Research|January 9, 2019
Machine Learning Models for the Prediction of Chemotherapy-Induced Peripheral NeuropathyPeter Bloomingdale, Donald E Mager
British Journal of Clinical Pharmacology|September 22, 2016
Population pharmacokinetics of exenatideBrenda Cirincione, Donald E Mager
CPT: Pharmacometrics & Systems Pharmacology|November 25, 2025
B Cell Differentiation Model for Identifying Predictors of Responses to Rituximab-Mediated B Cell Depletion in Rheumatic DiseasesTomohisa Nakada, Donald E Mager
Pageof 17